What we found on the web about Rosiglitazone
Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in ...
On July 30, 2007 an Advisory Committee of the Food and Drug Administration concluded that the use of rosiglitazone for the treatment of type 2 diabetes was associated with a ...
Find patient medical information for Rosiglitazone Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings
Important Safety Information about AVANDIA ® (rosiglitazone maleate) Prescription AVANDIA, along with diet and exercise, helps improve blood sugar control in adults with type 2 ...
Rosiglitazone may cause fluid retention (a condition where the body keeps excess fluid) that may lead to or worsen congestive heart failure (condition in which the heart is unable ...
PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to ...
Rosiglitazone and pioglitazone in the treatment of diabetes mellitus Odom et al. Am J Health Syst Pharm 2008;65:1846-1850. FULL TEXT . Rosiglitazone Treatment Reduces Diabetic Neuropathy ...
rosiglitazone /ro·sig·lit·a·zone/ (ro-sig-lit´ah-zōn) an antidiabetic agent that increases insulin sensitivity, used as the maleate salt in the treatment of type 2 diabetes ...
Use: Type 2 diabetes mellitus (noninsulin dependent, NIDDM): Monotherapy: Improve glycemic control as an adjunct to diet and exercise . Combination therapy: In combination with a ...
If you or a loved one have experienced an Avandia heart attack, Avandia stroke, Avandia congestive heart failure, or any Avandia-related cardiovascular disease, or if you have ...
Here is what users have to say about Rosiglitazone

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approx $2.5bn in 2006. The drug's patent expires in 2012.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!